For research use only. Not for therapeutic Use.
XHN96818 (CAT: I038419) is a small molecule compound that exhibits potent inhibitory activity against the enzyme diacylglycerol acyltransferase-1 (DGAT-1). DGAT-1 is an enzyme involved in triglyceride synthesis, playing a crucial role in lipid metabolism. By inhibiting DGAT-1, XHN96818 has the potential to modulate lipid levels and may have therapeutic applications in conditions such as obesity, metabolic disorders, and liver diseases. Further research is being conducted to explore the pharmacological properties and potential therapeutic uses of XHN96818 in preclinical and clinical settings.
Catalog Number | I038419 |
CAS Number | 99296-81-8 |
Synonyms | XHN96818; XHN 96818; XHN-96818; PC(22:6/22:6); 22:6/22:6-PC; |
Molecular Formula | C52H80NO8P |
Purity | 98% |
Target | Liposome |
Solubility | To be determined |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (R)-2-(((4E,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl)oxy)-3-(((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl)oxy)propyl (2-(trimethylammonio)ethyl) phosphate |
InChI | InChI=1S/C52H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-42-44-51(54)58-48-50(49-60-62(56,57)59-47-46-53(3,4)5)61-52(55)45-43-41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h8-11,14-17,20-23,26-29,32-35,38-41,50H,6-7,12-13,18-19,24-25,30-31,36-37,42-49H2,1-5H3/b10-8-,11-9-,16-14-,17-15-,22-20-,23-21-,28-26-,29-27-,34-32-,35-33-,40-38-,41-39+/t50-/m1/s1 |
InChIKey | XLKQWAMTMYIQMG-HLYPVUJLSA-N |
SMILES | O=P([O-])(OC[C@@H](COC(CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)=O)OC(CC/C=C/C/C=CC/C=CC/C=CC/C=CC/C=CCC)=O)OCC[N+](C)(C)C |